Aroa Biosurgery Ltd - Asset Resilience Ratio

Latest as of September 2025: 12.13%

Aroa Biosurgery Ltd (ARX) has an Asset Resilience Ratio of 12.13% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Aroa Biosurgery Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$11.56 Million
≈ $8.18 Million USD Cash + Short-term Investments

Total Assets

AU$95.27 Million
≈ $67.41 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2001–2025)

This chart shows how Aroa Biosurgery Ltd's Asset Resilience Ratio has changed over time. See net asset quality index of Aroa Biosurgery Ltd to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Aroa Biosurgery Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ARX market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$0.00 0%
Short-term Investments AU$11.56 Million 12.13%
Total Liquid Assets AU$11.56 Million 12.13%

Asset Resilience Insights

  • Moderate Liquidity: Aroa Biosurgery Ltd has 12.13% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

Aroa Biosurgery Ltd Industry Peers by Asset Resilience Ratio

Compare Aroa Biosurgery Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Inspire Medical Systems Inc
NYSE:INSP
Medical Devices 20.29%
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
Medical Devices 0.84%
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
Medical Devices 19.31%
Stratec SE
XETRA:SBS
Medical Devices 0.30%
Duearity AB
ST:DEAR
Medical Devices 145.62%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%

Annual Asset Resilience Ratio for Aroa Biosurgery Ltd (2001–2025)

The table below shows the annual Asset Resilience Ratio data for Aroa Biosurgery Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 13.00% AU$12.87 Million
≈ $9.10 Million
AU$98.94 Million
≈ $70.01 Million
-3.84pp
2024-03-31 16.84% AU$17.16 Million
≈ $12.14 Million
AU$101.88 Million
≈ $72.09 Million
-14.39pp
2023-03-31 31.23% AU$34.07 Million
≈ $24.10 Million
AU$109.07 Million
≈ $77.17 Million
-14.25pp
2022-03-31 45.48% AU$47.62 Million
≈ $33.70 Million
AU$104.71 Million
≈ $74.09 Million
+43.50pp
2021-03-31 1.99% AU$1.45 Million
≈ $1.03 Million
AU$73.12 Million
≈ $51.74 Million
+0.84pp
2020-03-31 1.14% AU$944.72K
≈ $668.45K
AU$82.54 Million
≈ $58.40 Million
+1.12pp
2019-03-31 0.03% AU$9.60K
≈ $6.79K
AU$37.96 Million
≈ $26.86 Million
-0.23pp
2018-03-31 0.26% AU$37.00K
≈ $26.18K
AU$14.30 Million
≈ $10.12 Million
-0.31pp
2017-03-31 0.57% AU$37.00K
≈ $26.18K
AU$6.52 Million
≈ $4.61 Million
+0.02pp
2016-03-31 0.55% AU$35.00K
≈ $24.76K
AU$6.36 Million
≈ $4.50 Million
+0.08pp
2015-03-31 0.47% AU$35.00K
≈ $24.76K
AU$7.51 Million
≈ $5.31 Million
+0.05pp
2014-03-31 0.42% AU$35.00K
≈ $24.76K
AU$8.41 Million
≈ $5.95 Million
+0.04pp
2013-03-31 0.37% AU$35.00K
≈ $24.76K
AU$9.36 Million
≈ $6.62 Million
+0.05pp
2012-03-31 0.32% AU$35.00K
≈ $24.76K
AU$10.93 Million
≈ $7.73 Million
-0.11pp
2011-03-31 0.43% AU$35.00K
≈ $24.76K
AU$8.07 Million
≈ $5.71 Million
-0.25pp
2010-03-31 0.68% AU$35.00K
≈ $24.76K
AU$5.13 Million
≈ $3.63 Million
+0.64pp
2009-03-31 0.04% AU$35.00K
≈ $24.76K
AU$83.08 Million
≈ $58.79 Million
-0.01pp
2008-03-31 0.05% AU$35.00K
≈ $24.76K
AU$71.60 Million
≈ $50.66 Million
-5.03pp
2007-03-31 5.08% AU$4.50 Million
≈ $3.18 Million
AU$88.53 Million
≈ $62.64 Million
-7.98pp
2005-03-31 13.06% AU$2.56 Million
≈ $1.81 Million
AU$19.60 Million
≈ $13.87 Million
-18.74pp
2004-03-31 31.80% AU$4.91 Million
≈ $3.47 Million
AU$15.44 Million
≈ $10.93 Million
-6.39pp
2003-03-31 38.19% AU$4.63 Million
≈ $3.28 Million
AU$12.12 Million
≈ $8.58 Million
-17.87pp
2002-03-31 56.06% AU$6.93 Million
≈ $4.90 Million
AU$12.37 Million
≈ $8.75 Million
+50.57pp
2001-03-31 5.49% AU$760.00K
≈ $537.75K
AU$13.85 Million
≈ $9.80 Million
--
pp = percentage points

About Aroa Biosurgery Ltd

AU:ARX Australia Medical Devices
Market Cap
$154.57 Million
AU$218.45 Million AUD
Market Cap Rank
#17621 Global
#519 in Australia
Share Price
AU$0.63
Change (1 day)
-2.33%
52-Week Range
AU$0.50 - AU$0.80
All Time High
AU$1.54
About

Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and co… Read more